We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Unigene Laboratories, Inc. and Upsher-Smith Laboratories, Inc. have jointly filed in the U.S. District Court for the Southern District of New York a patent infringement lawsuit against Apotex Inc., a Canadian generic pharmaceutical manufacturer, and Apotex Corp., its U.S. subsidiary.
Oscient Pharmaceuticals has agreed to acquire U.S. rights to the cardiovascular product ANTARA 130 mg (fenofibrate) capsules from Reliant Pharmaceuticals.
Reversing a strategy that had drawn criticism from doctors, Pfizer says that it will apply for approval to sell a promising new heart treatment as a standalone pill rather than only in combination with Lipitor, Pfizer's best-selling cholesterol treatment.
Seventeen more lawsuits have been filed against Pfizer alleging that the company misled patients and doctors with marketing that downplayed the risks associated with taking its cholesterol-lowering drug Lipitor, according to a press release by the lawyer representing the plaintiffs.
Sen. Mike Enzi (R-Wyo.) will hold a hearing next week on the Bush administration's nomination of Andrew von Eschenbach to be the next FDA commissioner, even though Democratic opponents are promising to continue their hold of the nominee, congressional aides said.
Momenta Pharmaceuticals, Inc.,a biotechnology company specializing in the characterization and engineering of complex drugs, announced an exclusive collaboration with Sandoz, the generics business of Novartis, to develop four follow-on and complex generic versions of previously approved recombinant biotechnology and complex drugs.